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The entry of a cell into DNA synthesis is a critical entry, but the way in which this enzyme promotes DNA
synthesis is poorly understood because few substratesregulation point for all living cells. A number of cyclins
have been identified. We are currently using a varietyand cyclin-dependent kinases (CDKs) have been impli-
of techniques to identify new substrates for cyclincated in the G1/S phase cell cycle transition.
E/cdk2. Two novel complexes have been identified: theThe D-type cyclins and their kinase partners CDK4
U2 complex of the splicing machinery and also compo-and CDK6 are involved in regulating the entry of cells
nents of the SWI/SNF chromatin remodeling apparatus.into the cell cycle from a quiescent state. It is believed
that unique mechanisms may serve to regulate these
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